You are here

  • Home
  • Archive
  • Volume 12, Issue 10
  • Prevalence of polypharmacy and associated adverse outcomes and risk factors among children with asthma in the USA: a cross-sectional study

Article metrics

Article menu
Pharmacology and therapeutics
Original research
Prevalence of polypharmacy and associated adverse outcomes and risk factors among children with asthma in the USA: a cross-sectional study

 

Online download statistics by month:

Online download statistics by month: October 2022 to April 2024

AbstractFullPdf
Oct 202288288071
Nov 202241940046
Dec 202238437135
Jan 202333532629
Feb 202319519222
Mar 202322821325
Apr 202354447
May 2023584724
Jun 2023534923
Jul 2023444019
Aug 2023251913
Sep 2023363013
Oct 2023585018
Nov 2023493316
Dec 2023363219
Jan 202430257
Feb 2024434024
Mar 2024584935
Apr 202427188
Total30142858454